Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald Preblick

Showing results (31-40 of 33) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 33 results.
Diabetes, Obesity & Metabolism|June 26, 2018
Clinical outcomes in real-world patients with type 2 diabetes switching from first- to second-generation basal insulin analogues: Comparative effectiveness of insulin glargine 300 units/mL and insulin degludec in the DELIVER D+ cohort studySean D Sullivan, Timothy S Bailey, Ronan Roussel, et al.
Clinical Therapeutics|October 8, 2019
Insights Into Patients' Experience With Type 1 Diabetes: Exit Interviews From Phase III Studies of SotagliflozinClaire Ervin, Vijay N Joish, Emily Evans, et al.
Diabetes, Obesity & Metabolism|December 3, 2019
Differences between patients with type 1 diabetes with optimal and suboptimal glycaemic control: A real-world study of more than 30 000 patients in a US electronic health record databaseJeremy H Pettus, Fang Liz Zhou, Leah Shepherd, et al.
Pageof 4

Showing results (31-40 of 33) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 33 results.
Diabetes, Obesity & Metabolism|June 26, 2018
Clinical outcomes in real-world patients with type 2 diabetes switching from first- to second-generation basal insulin analogues: Comparative effectiveness of insulin glargine 300 units/mL and insulin degludec in the DELIVER D+ cohort studySean D Sullivan, Timothy S Bailey, Ronan Roussel, et al.
Clinical Therapeutics|October 8, 2019
Insights Into Patients' Experience With Type 1 Diabetes: Exit Interviews From Phase III Studies of SotagliflozinClaire Ervin, Vijay N Joish, Emily Evans, et al.
Diabetes, Obesity & Metabolism|December 3, 2019
Differences between patients with type 1 diabetes with optimal and suboptimal glycaemic control: A real-world study of more than 30 000 patients in a US electronic health record databaseJeremy H Pettus, Fang Liz Zhou, Leah Shepherd, et al.
Pageof 4